Being the principal cause of death worldwide, the study of cardiovascular diseases is of high priority. Accurate cardiovascular diagnosis is imperative to guide appropriate clinical decision-making that ultimately translates into improved patient outcomes. Besides, medicine´s trend is slowly being re-directed to the early detection and prevention of diseases, including cardiovascular diseases. Our approach focuses on the use of imaging modalities to study cardiovascular health and transition to subclinical damage and stablished cardiovascular disease. We work on different aspects of cardiovascular disease prevention including pathophysiology of human atherosclerotic disease and lifestyle intervention strategies (closely collaborating in major CNIC projects such as the Progression of Early Subclinical Atherosclerosis [PESA] cardiovascular cohort). Among other tools, we use state-of-the-art conventional and advanced diagnostic modalities including ultrasound, cardiac magnetic resonance, computed tomography and positron emission tomography to study cardiovascular disease through the lifespan. We closely collaborate with other CNIC basic and clinical scientists, including biomedical engineers, to develop advanced image analysis and interpretation tools. Our research also includes translational approaches to study myocardial adaptation to pressure overload and early diagnosis of chronic pulmonary hypertension and right heart failure through the integration of advanced imaging and omics. Scientists from different disciplines who share our goals and vision are welcome in our team!